The effect of interleukin-12 and interleukin-15 on CD69 expression of T-lymphocytes and natural killer cells from umbilical cord blood

Biology of the Neonate

Volumn 78, Issue 3, 2000, Pages 181-185

  Lin, Syh Jae ^a   Chao, Hsun Chin ^a   Kuo, Ming Ling ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

CD69; Cord blood; Interleukin 12; Interleukin 15

Indexed keywords

CD69 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15;

ADULT; ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NATURAL KILLER CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 0033756422     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014268     Document Type: Article

References (25)

1. Immunoglobulin and cytokine production by neonatal lymphocytes
2. Decreased production of interferon-γ by human neonatal cells
3. Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12
4. Human neonatal natural killer cytotoxicity function
5. Human umbilical cord blood for hematopoietic progenitor cells transplantation
6. Umbilical cord blood as a new and promising source of unrelated-donor hematopoietic stem cells for transplantation
7. Interleukin-12: A cytokine produced ny antigen-presenting cells with immunoregulatory function in the generation of T-helper cells with type-1 and cytotoxic lymphocytes
8. Interleukin-15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor
9. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity
10. Interleukin (IL)-15 enhances natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) in neonatal cells
11. Human immunodeficiency virus (HIV) type-1 gp120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected subjects: Enhancement with IL-2, IL-12, IL-15
12. Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular activity (ADCC) in HIV infection
13. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vi-tro: Synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2
14. CD69 and regulation of the immune function
15. T cell activation via Leu-23 (CD69)
16. Expression of CD69 after in vitro stimulation: A rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals
17. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma
18. Developmental immunology of the newborn
19. The role of natural killer cells in human disease
20. Characterization of functional surface structure of human natural killer cells
21. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response
22. IL-2 and IL-7 but not IL-12 protects natural killer cells from death by apoptosis and upregulates bcl-2 expression
23. Rational interleukin-2 therapy for HIV positive individuals: Daily low doses enhance immune function without toxicity
24. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous IL-15
25. Studies evaluating antitumor activity and toxicity of interleukin-15, a new T cell growth factor: Comparison with IL-2